ARPC5 and colorectal adenocarcinoma: A total of 961, 500, and 500 tumors as well as 836, 413, and 434 paracarcinoma normal tissues from 993, 509, and 509 subjects with colorectal adenocarcinoma were informative for CORO1C, RAD23B, and ARPC5, respectively (Fig. 1 and Supplementary Data 11–13).